BlackRock Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$401K	Buy	22,653 +536	+2%	+$9.42K	﹤0.01%	2331
2016 Q3	$427K	Buy	22,117 +1,513	+7%	+$29.6K	﹤0.01%	2258
2016 Q2	$402K	Buy	20,604 +876	+4%	+$17.2K	﹤0.01%	2237
2016 Q1	$407K	Buy	19,728 +1,521	+8%	+$30K	﹤0.01%	2190
2015 Q4	$374K	Sell	18,207 -8,778	-33%	-$168K	﹤0.01%	2240
2015 Q3	$461K	Sell	26,985 -840	-3%	-$15.4K	﹤0.01%	2248
2015 Q2	$519K	Buy	27,825 +988	+4%	+$18.3K	﹤0.01%	2160
2015 Q1	$512K	Buy	26,837 +3,906	+17%	+$72.2K	﹤0.01%	2054
2014 Q4	$377K	Sell	22,931 -972	-4%	-$16.7K	﹤0.01%	2203
2014 Q3	$423K	Sell	23,903 -475	-2%	-$9.33K	﹤0.01%	2107
2014 Q2	$503K	Sell	24,378 -4,055	-14%	-$83.3K	﹤0.01%	2018
2014 Q1	$620K	Sell	28,433 -58,939	-67%	-$1.35M	﹤0.01%	1903
2013 Q4	$2.32M	Sell	87,372 -25,807	-23%	-$634K	﹤0.01%	1141
2013 Q3	$2.67M	Buy	113,179 +5,689	+5%	+$133K	﹤0.01%	1109
2013 Q2	$2.31M	Buy	+107,490	New	+$2.32M	﹤0.01%	1116

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BlackRock Advisors's VIVO Position: Q4 2016 in Review

BlackRock Advisors increased its Meridian Bioscience Inc (VIVO) stake by 2.4% in Q4 2016, buying an estimated $9.42K and bringing the position to 22,653 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #2331.

BlackRock Advisors first reported a position in VIVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.67M in Q3 2013. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

BlackRock Advisors held 22,653 shares of Meridian Bioscience Inc worth $401K as of Q4 2016.
BlackRock Advisors bought 536 Meridian Bioscience Inc shares in Q4 2016, an estimated $9.42K.
Meridian Bioscience Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2331 holding.
BlackRock Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Meridian Bioscience Inc position peaked at $2.67M in Q3 2013.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.